The use of isoenzyme-selective phosphodiesterase (PDE) inhibitors is considered a great opportunity to treat various diseases of the human urogenital tract. PDE inhibitors, in particular the PDE5 ...

A new study reports that mirodenafil, a newly developed oral phosphodiesterase type 5 (PDE5) inhibitor, is an efficacious and safe treatment for erectile dysfunction (ED). Many men with ED ...

Aimed at improving cancer therapeutics, a doctorate student at Purdue University, Lukman Bello has published research on the rational design and optimisation of novel PDE5 inhibitors for targeted ...